Stockscreener 앱 받기
54.41
2.18%
-1.21
시간 외 거래:
55.45
1.04
+1.91%
Procept Biorobotics Corp 주식(PRCT)의 최신 뉴스
Procept BioRobotics Corp (PRCT) expanding its growth trajectory ahead - Sete News
Leerink Partnrs Has Negative Outlook of PRCT Q2 Earnings - Defense World
Market Insight: Procept BioRobotics Corp (PRCT)’s Notable Drop, Closing at 53.98 - DWinneX
William Blair Issues Pessimistic Forecast for PRCT Earnings - Defense World
Did Procept BioRobotics Corp (PRCT) perform well in the last session? - uspostnews.com
Mariner LLC Purchases 2,429 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
PROCEPT BioRobotics Leadership to Present at Four Premier Healthcare Investment Conferences - Stock Titan
Leerink cuts Procept BioRobotics price target to $90, keeps outperform By Investing.com - Investing.com Nigeria
Promising Potential of PROCEPT BioRobotics’ Aquablation Technology in Prostate Cancer Treatment Drives Buy Rating - TipRanks
Leerink cuts Procept BioRobotics price target to $90, keeps outperform - Investing.com
Bank of America Cuts PROCEPT BioRobotics (NASDAQ:PRCT) Price Target to $84.00 - Defense World
Procept BioRobotics Corp [PRCT] Records 50-Day SMA of $58.96 - knoxdaily.com
Procept BioRobotics price target lowered to $84 from $104 at BofA - TipRanks
Closing Figures: Procept BioRobotics Corp (PRCT)’s Negative Finish at 52.56, Down -5.64 - DWinneX
Procept BioRobotics Corp [PRCT] stock Initiated by Morgan Stanley analyst, price target now $105 - dbtnews.com
Where PROCEPT BioRobotics Stands With Analysts - Benzinga
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2025 Earnings Call Transcript - Insider Monkey
Procept BioRobotics (PRCT) Target Price Cut to $84 by BofA Analy - GuruFocus
Procept BioRobotics reports Q1 EPS (45c), consensus (49c) - TipRanks
PROCEPT BioRobotics (NASDAQ:PRCT) Sees Large Volume Increase on Earnings Beat - Defense World
PROCEPT BioRobotics Sees Strong Revenue Growth in Q1 2025 - TipRanks
Earnings call transcript: Procept Biorobotics beats Q1 2025 EPS forecast By Investing.com - Investing.com India
Procept Biorobotics Corp. Reports Strong Q1 Growth Amid Challenges - TipRanks
Procept BioRobotics sees FY25 revenue $323M, consensus $321.67M - TipRanks
Breakthrough BPH Treatment: Experts Reveal Long-Term Aquablation Results at Major Urology Conference - Stock Titan
Morgan Stanley lowers Procept BioRobotics price target, sees buying opportunity - TipRanks
Procept BioRobotics Corp’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - investchronicle.com
PROCEPT BioRobotics (PRCT) Sees Significant Revenue Growth in Q1 2025 - GuruFocus
Procept BioRobotics Corp (NASDAQ:PRCT): It’s all about numbers this morning - uspostnews.com
Nothing is Better Than Procept BioRobotics Corp (PRCT) stock at the moment - Sete News
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates - MSN
Earnings call transcript: Procept Biorobotics beats Q1 2025 EPS forecast - Investing.com
Procept Biorobotics earnings beat by $0.04, revenue topped estimates - Investing.com
Why Procept Biorobotics Shares Are Under Pressure - TipRanks
PROCEPT BioRobotics Reports First Quarter 2025 Financial Results - TradingView
12-Month Price Target For Procept BioRobotics Corp (NASDAQ:PRCT) Now Sits At 105 - Marketing Sentinel
PROCEPT Crushes Q1 Expectations: 55% Revenue Growth, International Sales Double, 2025 Guidance Raised - Stock Titan
LPL Financial LLC Boosts Stake in PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Shares Sold by Wells Fargo & Company MN - Defense World
Piper Sandler maintains $100 target on Procept BioRobotics stock By Investing.com - Investing.com Canada
Piper Sandler maintains $100 target on Procept BioRobotics stock - Investing.com Australia
Analysts Set PROCEPT BioRobotics Co. (NASDAQ:PRCT) PT at $91.43 - Defense World
Truist Financial Cuts PROCEPT BioRobotics (NASDAQ:PRCT) Price Target to $70.00 - Defense World
Leading Urologists Join PROCEPT BioRobotics Leadership for Exclusive Investor Insights - Stock Titan
JPMorgan Chase & Co. Lowers Stock Holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
Vanguard Group Inc. Purchases 297,075 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
Corebridge Financial Inc. Sells 496 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
Raymond James Financial Inc. Purchases Shares of 20,453 PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
HighTower Advisors LLC Buys 1,026 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
Sei Investments Co. Grows Stake in PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
Teacher Retirement System of Texas Takes Position in PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
PROCEPT BioRobotics (PRCT): One of the Best Robotics Stocks to Buy According to Billionaires - Insider Monkey
10 Best Robotics Stocks to Buy According to Billionaires - Insider Monkey
Aquablation therapy shows promise in prostate treatment By Investing.com - Investing.com Australia
Aquablation therapy shows promise in prostate treatment - Investing.com India
11.62%
0.20%
자본화:
|
볼륨(24시간):